Insider · CIK 0001166776
Paul Thomas
Files at AXGN (Axogen, Inc.). First filing Dec 10, 2025, latest Dec 10, 2025.
Paul Thomas files SEC Form 4 as director at AXGN (Axogen, Inc.). Since Dec 10, 2025, Paul Thomas has reported 0 open-market buys worth $0 and 1 open-market sell worth $634k, the latest filed on Dec 10, 2025.
A track record needs three past buys with six months of prices behind them; Paul Thomas has 0, so none is measured yet.
The newest scored trade: sold $634k of AXGN on Dec 9, 2025, filed Dec 10, 2025, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $634k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXGN: Axogen, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | Axogen, Inc. | $634k 21,399 shares | -61% | +229% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 9, 2025 | AXGN AXOGEN, INC. | 21,399 0.05% of outstanding | $634k | Dec 9, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +5,579 | $0.00 | $0 | 5,579 | Jun 26, 2026 |
| Jun 19, 2026 | AXGN Axogen, Inc. | MOption exercise Common Stock | +18,867 | $0.00 | $0 | 32,395 | Jun 23, 2026 |
| Jun 19, 2026 | AXGN Axogen, Inc. | MOption exercise Restricted Stock Unitsderivative | +18,867 | $0.00 | $0 | 0 | Jun 23, 2026 |
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -21,399 | $29.61 | $634k | 13,528 | Dec 10, 2025 |
| Jun 19, 2025 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +18,867 | $0.00 | $0 | 18,867 | Jun 20, 2025 |
Questions about Paul Thomas
Answered from the filings on this page, as of the latest one.
Is Paul Thomas buying or selling?
In the last 12 months Paul Thomas reported 0 open-market buys worth $0 and 1 open-market sell worth $634k on SEC Form 4; the latest was sold $634k of AXGN on Dec 9, 2025. Grants, option exercises and tax withholding are not counted.
How did Paul Thomas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Thomas has 0.
Where does Paul Thomas file Form 4?
Paul Thomas has filed Form 4 at AXGN (Axogen, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.